Search for Clinical Trial Results

Hemorrhagic Fevers, Viral - 25 Studies Found
Status | Study |
Enrolling by invitation |
Study Name: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever Condition: Viral Hemorrhagic Fever Date: 2015-06-24 Interventions: Drug: Ribavirin |
Enrolling by invitation |
Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome Condition: Hemorrhagic Fever With Renal Syndrome Date: 2008-02-13 Interventions: Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day |
Active, not recruiting |
Study Name: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans Condition: Crimean-Congo Hemorrhagic Fever Date: 2017-01-11 Interventions:
|
Withdrawn |
Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany Condition: Hemorrhagic Fever With Renal Syndrome Date: 2009-03-24 Interventions: Drug: Virazole (Ribavirin) Duration of Subject Participati |
Active, not recruiting |
Study Name: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Condition: Hemorrhagic Fever With Renal Syndrome Date: 2014-04-14 Interventions:
|
Enrolling by invitation |
Study Name: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities Condition:
Date: 2009-10-08 Interventions: Drug: Ribavirin (Virazole) Injection The drug is to be adm |
Completed |
Study Name: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever Condition:
Date: 2012-05-14 Interventions:
|
Active, not recruiting |
Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda Condition: Hemorrhagic Fever, Ebola Date: 2015-01-29 Interventions:
|
Recruiting |
Study Name: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi Condition: Ebola Hemorrhagic Fever Date: 2016-09-14 Interventions: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c |
Completed |
Study Name: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Condition: Hemorrhagic Fever With Renal Syndrome Date: 2011-12-23 Interventions: Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio |